Advanced search
Publication Cover
Future Science OA Volume 10, 2024 - Issue 1
Submit an article Journal homepage
317
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Multi-epitope vaccine against SARS-CoV-2 targeting the spike RBD: an immunoinformatics approach

Yasamin Pahlavan1 Biosensor Sciences and Technologies Research Center, Ardabil University of Medical Sciences, Ardabil, 56189-85991, IranORCID Iconhttps://orcid.org/0000-0002-4681-8807
ORCID Icon,
Omid Yeganeh2 Department of Microbiology, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, 16511-53311, IranORCID Iconhttps://orcid.org/0000-0003-0512-7193
ORCID Icon,
Vahid Asghariazar3 Cancer Immunology and Immunotherapy Research Center, Ardabil University of Medical Sciences, Ardabil, 56189-85991, IranORCID Iconhttps://orcid.org/0000-0002-9809-6711
ORCID Icon &
Chiman Karami4 Department of Microbiology, Parasitology and Immunology, Ardabil University of Medical Sciences, Ardabil, 56189-85991, IranCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6728-5432
ORCID Icon
Article: FSO939 | Received 10 May 2023, Accepted 07 Nov 2023, Published online: 20 May 2024

References

  • Kubiak JZ, Kloc M. Coronavirus disease pathophysiology: biomarkers, potential new remedies, comorbidities, long COVID-19, post pandemic epidemiological surveillance. MDPI 12236 (2023).
  • Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol. 20(5), 270–284 (2022).
  • Habibzadeh S et al. COVID-19: From the Molecular Mechanisms to Treatment. Tanaffos 21(2), 113 (2022).
  • Savan R, Gale M. Innate immunity and interferon in SARS-CoV-2 infection outcome. Immunity 56(7), 1443–1450 (2023).
  • Borczuk AC, Yantiss RK. The pathogenesis of coronavirus-19 disease. J. Biomed. Sci. 29(1), 87 (2022).
  • Matin S et al. The sufficient vitamin D and albumin level have a protective effect on COVID-19 infection. Arch. Microbiol. 203, 5153–5162 (2021).
  • Wolter N et al. Clinical severity of SARS-CoV-2 Omicron BA. 4 and BA. 5 lineages compared to BA. 1 and Delta in South Africa. Nat. Comm. 13(1), 5860 (2022).
  • Lewnard JA et al. Association of SARS-CoV-2 BA. 4/BA. 5 Omicron lineages with immune escape and clinical outcome. Nature Comm. 14(1), 1407 (2023).
  • Li G et al. Therapeutic strategies for COVID-19: progress and lessons learned. Nat. Rev. Drug Dis. 1–27 (2023).
  • Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respiratory Soc (2020).
  • Lamprinou M et al. COVID-19 vaccines adverse events: potential molecular mechanisms. Immunol. Res. 71(3), 356–372 (2023).
  • Dai L, Gao GF. Viral targets for vaccines against COVID-19. Nat. Rev. Immunol. 21(2), 73–82 (2021).
  • Suleman M et al. Characterization of proteome wide antigenic epitopes to design proteins specific and proteome-wide ensemble vaccines against heartland virus using structural vaccinology and immune simulation approaches. Microb. Pathog. 168, 105592 (2022).
  • Chen H-Z et al. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2. Inf. Dis. Pov. 9(1), 1–10 (2020).
  • Rauch S et al. New vaccine technologies to combat outbreak situations. Front. Immunol. 9, 1963 (2018).
  • Waqas M, Haider A, Rehman A et al. Immunoinformatics and molecular docking studies predicted potential multiepitope-based peptide vaccine and novel compounds against novel SARS-CoV-2 through Virtual screening. BioMed Res. Int. 2021, 1596834 (2021).
  • Harun-Ur-Rashid M et al. Rapid diagnosis of COVID-19 via nano-biosensor-implemented biomedical utilization: a systematic review. RSC Adv. 12(15), 9445–9465 (2022).
  • Dargahi A et al. Investigation of SARS CoV-2 virus in environmental surface. Environ. Res. 195, 110765 (2021).
  • Khairkhah N et al. Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen. PLOS ONE 17(6), e0268251 (2022).
  • Yeganeh O et al. Production and characterization of novel monoclonal antibodies against outer membrane protein A (OmpA) of Acinetobacter baumannii. J. Immunol. Methods 499, 113169 (2021).
  • Pahlavan Y et al. Survivin modulatory role in autoimmune and autoinflammatory diseases. J. Cell. Physiol. 234(11), 19440–19450 (2019).
  • Moret M, Zebende G. Amino acid hydrophobicity and accessible surface area. Phys. Rev. E 75(1), 011920 (2007).
  • Srivastava S et al. Structural basis for designing multiepitope vaccines against COVID-19 infection: in silico vaccine design and validation. JMIR Bioinform. Biotechnol. 1(1), e19371 (2020).
  • Noorimotlagh Z et al. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: a systematic review. Int. Immunopharmacol. 86, 106738 (2020).
  • Sanami S et al. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach. Int. J. Biol. Macromol. 164, 871–883 (2020).
  • Yarmarkovich M, Warrington JM, Farrel A, Maris JM. Identification of SARS-CoV-2 vaccine epitopes predicted to induce long-term population-scale immunity. Cell Reports Med. 1(3), 100036 (2020).
  • de Oliveira Campos DM et al. Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants. Comput. Biol. Chem. 101, 107754 (2022).
  • McGill JR et al. A structural homology approach to identify potential cross-reactive antibody responses following SARS-CoV-2 infection. Scientific Reports 12(1), 11388 (2022).
  • Pandey A, Madan R, Singh S. Immunology to Immunotherapeutics of SARS-CoV-2: Identification of Immunogenic Epitopes for Vaccine Development. Curr. Microbiol. 79(10), 306 (2022).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.